Status:
COMPLETED
The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control Study
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
In order to improve postoperative ileus in patients undergoing gastrointestinal surgery, digestive medications and prokinetics have been routinely used. Among them, mosapride citrate is widely used as...
Eligibility Criteria
Inclusion
- Patients diagnosed with gastric adenocarcinoma pathologically before surgery
- Patients who underwent complete surgical resection (R0 resection)
- Patients with an ASA score of 3 or less
Exclusion
- Patients over 80 years of age
- Ascites or peritoneal metastasis
- If you have intestinal obstruction before surgery
- If chemotherapy was performed before surgery
- If cancer other than gastric cancer is diagnosed
- If there is a history of previous major intra-abdominal long-term surgery or abdominal radiation therapy
- In case of liver failure or renal failure
- Pregnant women
- If it is judged that uncontrolled diabetes can affect intestinal function
- If you have a stoma
Key Trial Info
Start Date :
January 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05966246
Start Date
January 25 2022
End Date
June 30 2023
Last Update
August 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GangnamSeverance Hospital
Seoul, South Korea